The observer-blind, randomised controlled study to determine the safety and immunogenicity of "Covishield" on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/2Qt0Zt3